Publications

• The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.
  Urol Case Rep Volume: 57 Page(s): 102875
  11/01/2024 Authors: Palmateer G; Nicaise EH; Gandhi J; Goodstein T; Sheng M; Ogan K; Kucuk O; Yushak M; Sanda MG; Delman KA
• Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.
  J Clin Oncol Volume: 42 Page(s): 2928 - 2938
  08/20/2024 Authors: Hamid O; Lewis KD; Weise A; McKean M; Papadopoulos KP; Crown J; Kim TM; Lee DH; Thomas SS; Mehnert J
• Tregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactions.
  J Clin Invest Volume: 134
  05/02/2024 Authors: Duffy A; Azeem MI; Kanangat S; Yushak M; Lawson D; Dhodapkar MV; Dhodapkar KM
• Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy.
  JID Innov Volume: 3 Page(s): 100232
  11/01/2023 Authors: Yeung H; Supapannachart KJ; Francois S; Adler CH; Kudchadkar RR; Lawson DH; Yushak ML; Shariff AI; Chen SC
• Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma.
  Cancer Res Commun Volume: 2 Page(s): 904 - 913
  08/01/2022 Authors: Andtbacka RHI; Wang Y; Pierce RH; Campbell JS; Yushak M; Milhem M; Ross M; Niland K; Arbeit RD; Parasuraman S
• Impact of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma (the MEMOIR study): A propensity score-matched analysis
  Volume: 33 Page(s): S12 - S12
  03/08/2022 Authors: Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM
• Clinical Correlation between Acute Exudative Polymorphous Paraneoplastic Vitelliform Maculopathy and Metastatic Melanoma Disease Activity: A 48-month Longitudinal Case Report.
  Ocul Immunol Inflamm Volume: 30 Page(s): 330 - 337
  02/17/2022 Authors: Mueller CM; Hojjatie SL; Lawson DH; Jain N; Robinson J; Khan MK; Yushak ML; A Datoo O'Keefe G
• Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition.
  Front Oncol Volume: 12 Page(s): 836845
  01/01/2022 Authors: Knochelmann HM; Ware MB; Rali A; Linderman S; Shantha JG; Lawson DH; Yushak M; Swerlick R; Paulos CM; Yeh S
• Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
  Lancet Oncol Volume: 22 Page(s): 1777 - 1786
  12/01/2021 Authors: Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM
• Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
  N Engl J Med Volume: 385 Page(s): 1196 - 1206
  09/23/2021 Authors: Nathan P; Hassel JC; Rutkowski P; Baurain J-F; Butler MO; Schlaak M; Sullivan RJ; Ochsenreither S; Dummer R; Kirkwood JM
• Exploring the melanoma survivorship experience: a qualitative study.
  Br J Dermatol Volume: 185 Page(s): 221 - 223
  07/01/2021 Authors: Wolner ZJ; Flowers NI; Yushak ML; Chen SC; Yeung H
• Institutional Outcomes of Whole Brain Radiotherapy for Metastatic Melanoma Brain Metastases
  Volume: 108 Page(s): E687 - E687
  11/01/2020 Authors: Jiang C; Switchenko J; Lawson D; Yushak M; Khan MK
• Changing Therapeutic Landscape for Melanoma With Multiple Brain Metastases.
  Neurosurgery Volume: 87 Page(s): 498 - 515
  09/01/2020 Authors: Jiang C; Wallington DG; Anker CJ; Lawson DH; Yushak ML; Kudchadkar RR; Tarhini A; Khan MK
• Institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases.
  Volume: 38
  05/20/2020 Authors: Jiang C; Switchenko JM; Lawson DH; Yushak ML; Khan MK
• Interim results of prospective pilot phase II trial of concurrent anti-PD-1 and stereotactic radiosurgery (SRS) for melanoma and NSCLC patients with brain metastases (NCT02858869).
  Volume: 38
  05/20/2020 Authors: Khan MK; Nasti T; Yushak ML; Lawson DH; Switchenko JM; Wallington D; Kleber T; Kirmani K; Owonikoko TK; Ramalingam SS
• Integrated biomarker study of neoadjuvant pepinemab and nivolumab in patients with resectable metastatic melanoma.
  Volume: 38
  05/20/2020 Authors: Lowe MC; Olson B; Martinez A; Hammons J; Delman KA; Yushak ML; Allor M; Reilly CA; Mallow CL; Evans EE
• Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases.
  Sci Adv Volume: 6 Page(s): eaav7504
  02/01/2020 Authors: Tan S; Yang H; Xue S; Qiao J; Salarian M; Hekmatyar K; Meng Y; Mukkavilli R; Pu F; Odubade OY
• Predictors of Overall and Progression-Free Survival in Patients with Ocular Melanoma Metastatic to the Liver Undergoing Y90 Radioembolization.
  Cardiovasc Intervent Radiol Volume: 43 Page(s): 254 - 263
  02/01/2020 Authors: Levey AO; Elsayed M; Lawson DH; Ermentrout RM; Kudchadkar RR; Bercu ZL; Yushak ML; Newsome J; Kokabi N
• Surgical Considerations and Systemic Therapy of Melanoma.
  Surg Clin North Am Volume: 100 Page(s): 141 - 159
  02/01/2020 Authors: Gamboa AC; Lowe M; Yushak ML; Delman KA
• Multiple keratin granulomata: A potential histologic clue to cutaneous squamous cell carcinoma responding to programmed cell death protein 1 inhibitor therapy.
  J Cutan Pathol Volume: 46 Page(s): 452 - 454
  06/01/2019 Authors: Kahn BJ; Parker D; Yushak M; Stoff B; Blalock TW
• Pilot integrated biomarker study of VX15/2503 in combination with ipilimumab and/or nivolumab in patients with resectable metastatic melanoma.
  Volume: 37
  05/20/2019 Authors: Lowe MC; Lesinski GB; Delman KA; Yushak ML; Evans EE; Fisher TL; Kudchadkar RR
• Approaches to High-Risk Resected Stage II and III Melanoma.
  Am Soc Clin Oncol Educ Book Volume: 39 Page(s): e207 - e211
  01/01/2019 Authors: Yushak M; Mehnert J; Luke J; Poklepovic A
• The importance of surgery in scalp angiosarcomas.
  Surg Oncol Volume: 27 Page(s): A3 - A8
  12/01/2018 Authors: Cassidy RJ; Switchenko JM; Yushak ML; Madden N; Khan MK; Monson DK; Beitler JJ; Landry JC; Godette KD; Gillespie TW
• Pre- vs Post-Operative Radiation Therapy, and Time to Surgery: An Exploratory Analysis of Predictors of Survival in Soft Tissue Sarcoma Stratified by Histological Subtype
  Volume: 102 Page(s): E206 - E206
  11/01/2018 Authors: Buchwald ZS; Fortune C; Zhang C; Abugideiri M; Jhaveri J; Press RH; Morgan T; Tian S; Yushak M; Godette KD
• Phase II trial of pembrolizumab (MK-3475) in metastatic cutaneous squamous cell carcinoma (cSCC)
  Volume: 36
  05/20/2018 Authors: Kudchadkar RR; Yushak ML; Lawson DH; Delman KA; Lowe MC; Goings M; McBrien S; Mckellar M; Sieja K; Maynard N
• X4P-001, an orally bioavailable CXCR4 antagonist, increases T cell infiltration in human metastatic melanoma
  Volume: 5
  11/07/2017 Authors: Andtbacka R; Yushak M; Ross M; Grossman K; Tsiroyanni E; Blanchette S; Gan L; Wang Y; Milhem M
• Systemic Therapy Options for Patients With Unresectable Melanoma.
  Am Soc Clin Oncol Educ Book Volume: 37 Page(s): 661 - 672
  01/01/2017 Authors: Yushak M; Chapman P; Robert C; Kudchadkar R
• Patient preferences regarding incidental genomic findings discovered during tumor profiling.
  Cancer Volume: 122 Page(s): 1588 - 1597
  05/15/2016 Authors: Yushak ML; Han G; Bouberhan S; Epstein L; DiGiovanna MP; Mougalian SS; Sanft TB; Abu-Khalaf MM; Chung GG; Stein SM
• Clinical trials in melanoma patients with brain metastases.
  Pigment Cell Melanoma Res Volume: 28 Page(s): 741 - 743
  11/01/2015 Authors: Yushak ML; Chiang VL; Kluger HM
• Patient preferences for disclosure of incidental genetic information discovered through high-throughput sequencing
  Volume: 75
  08/01/2015 Authors: Yushak ML; Bouberhan S; Han G; Epstein L; Mougalian S; Abu-Khalaf M; Chung G; DiGiovanna M; Sanft T; Pusztai L
• Discovery and disclosure of incidental genetic information obtained through high throughput sequencing.
  Volume: 33
  05/20/2015 Authors: Hofstatter EW; Yushak ML; Bouberhan S; Han G; Epstein L; Pusztai L
• Tumor profiling and the incidentalome: patient decisions and risks.
  Future Oncol Volume: 11 Page(s): 3299 - 3305
  01/01/2015 Authors: Hofstatter E; Mehra K; Yushak M; Pusztai L
• Advances in the systemic treatment of metastatic melanoma.
  Oncology (Williston Park) Volume: 27 Page(s): 374 - 381
  05/01/2013 Authors: Yushak M; Kluger HM; Sznol M
• Understanding patients' attitudes toward communication about the cost of cancer care.
  J Oncol Pract Volume: 8 Page(s): e50 - e58
  07/01/2012 Authors: Bullock AJ; Hofstatter EW; Yushak ML; Buss MK
• Regulation of neural progenitor cell fate by anandamide.
  Biochem Biophys Res Commun Volume: 400 Page(s): 21 - 26
  09/10/2010 Authors: Soltys J; Yushak M; Mao-Draayer Y
• False positive reactivity of recombinant, diagnostic, glycoproteins produced in High Five insect cells: effect of glycosylation.
  J Immunol Methods Volume: 330 Page(s): 130 - 136
  01/31/2008 Authors: Hancock K; Narang S; Pattabhi S; Yushak ML; Khan A; Lin S-C; Plemons R; Betenbaugh MJ; Tsang VCW
• Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis.
  Mol Biochem Parasitol Volume: 147 Page(s): 109 - 117
  05/01/2006 Authors: Hancock K; Pattabhi S; Whitfield FW; Yushak ML; Lane WS; Garcia HH; Gonzalez AE; Gilman RH; Tsang VCW
• Application of physiologically-based pharmacokinetic modeling to investigate the toxicological interaction between chlorpyrifos and parathion in the rat.
  Volume: 16 Page(s): 57 - 71
  03/01/2004 Authors: El-Masri HA; Mumtaz MM; Yushak ML
• Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis.
  Mol Biochem Parasitol Volume: 133 Page(s): 115 - 124
  01/01/2004 Authors: Hancock K; Pattabhi S; Greene RM; Yushak ML; Williams F; Khan A; Priest JW; Levine MZ; Tsang VCW
• Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis.
  J Clin Microbiol Volume: 41 Page(s): 2577 - 2586
  06/01/2003 Authors: Hancock K; Khan A; Williams FB; Yushak ML; Pattabhi S; Noh J; Tsang VCW